TrialJournal for immunotherapy of cancer2017

Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC.

Caroline Tosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.